astrostem

Cell therapyexperimental

Clinical trial activity

3 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Apr 3, 2017 (NCT03117738)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    Tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • astrostem

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04482413Phase 2Dec 1, 2020Nature Cell Co. Ltd.
NCT03979898Early Phase 1 (Phase 1)Jun 15, 2017Kyung Hee University, R-Biopharm
NCT03117738Phase 1/Phase 2 (Phase 2)Apr 3, 2017KCRN Research, Nature Cell Co. Ltd.
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Nature Cell Co. Ltd.For profit2212017
KCRN ResearchFor profit1012017
Kyung Hee UniversityAcademic/Hospital1012017
R-BiopharmFor profit1112017
4 organizations
Page 1 / 1